Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A16560 | Pages: 200 | Charts: 55 | Tables: 135 |
The global kyphoplasty market size was valued at $632.45 million in 2021, and is projected to reach $1.2 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. A surgical treatment called kyphoplasty is used to widen and stabilize spinal compression fractures. It involves injecting a specific cement into the spine and creating space for the procedure with a balloon-like device. Kyphoplasty is a kind of vertebroplasty that restores the height of a damaged vertebra while also reducing pain. It is one of the treatments for vertebral body compression fractures, which are tiny breaks in the thick bone mass that makes up the front segment of the spinal cord.
Get more information on this report : Request Sample Pages
Patients who are not improving with their current therapy and are in danger of significant deterioration might consider kyphoplasty. It's a pretty particular treatment that's only used in patients who've suffered a vertebral fracture, and not for other causes such as disc rupture or arthritis. Untreated vertebral compression fractures can have substantial clinical effects and have a considerable influence on the quality of life of patients as well as caretakers. Because non-surgical treatment of these fractures is ineffective, kyphoplasty operations for fracture stabilization and pain control are becoming more common in medical practice.
The drivers contributing to the growth of the kyphoplasty market include increase in elderly population, increase in incidence of osteoporosis and arthritis, increase in frequency of spine problems, and increase in patient knowledge regarding innovations in spine procedures. Furthermore, the market's push toward minimally invasive spine operations is a crucial trend that is expected to drive the development throughout the forecast period. Risks associated with post-surgical complications are projected to stifle market expansion, particularly poor reimbursement circumstances.
The kyphoplasty market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is categorized into kyphoplasty systems and accessories. By indication, it is divided into osteoporosis and others. By end user, it is segmented into hospitals & clinics and ambulatory surgical centers.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Depending on product, the accessories segment held the largest share in the global market in 2021 and is expected to remain dominant during the forecast period, owing to increase in demand for bone cements and biopsy kits due to surge in vertebral related cancer cases. The kyphoplasty systems segment is expected to witness highest CAGR of 6.6% during the kyphoplasty market forecast period, owing to various development and launch of products such as the balloon inflation devices and bone access devices.
[PRODUCTGRAPH]
Depending on indication, the osteoporosis segment held the largest kyphoplasty market share in the global market in 2021 with and is expected to remain dominant during the forecast period, owing to increase in geriatric population and rise in osteoporosis cases globally. The others segment is expected to witness highest kyphoplasty market growth of 7.2% during the forecast period owing to surge in road accidents, sports injuries and cancer cases among the population.
[INDICATIONGRAPH]
Depending on end user, the hospitals & clinics segment held the largest kyphoplasty market size in 2021 with and is expected to remain dominant during the forecast period, owing to increase in number of hospital admissions for vertebral compression fractures and accidental injuries to spinal cord. The ambulatory surgical centers segment is expected to witness highest CAGR of 7.2% during the forecast period owing to surge in osteoporosis diagnosis and demand for ASCs owing to their specific care and comfortable settings for elderly.
[ENDUSERGRAPH]
Region wise, North America is expected to account for the largest kyphoplasty market size, owing to established robust infrastructure of hospitals, advanced technology and availability of key players across the region, followed by Europe, Asia-Pacific, and LAMEA. Asia-Pacific is expected to register the fastest CAGR during the forecast period, due to increase in geriatric population, rapid development in healthcare technology, and increase in public–private investment. Moreover, India and China are expected to offer lucrative kyphoplasty market opportunity and are set to witness growth at high CAGR in the kyphoplasty market of Asia-Pacific.
[REGIONGRAPH]
The key players operating in the global kyphoplasty industry are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.
Key Market Segments
Key Market Players